Suppr超能文献

SARS-CoV-2 NSP1 对抗病毒基因的表观遗传抑制。

Epigenetic repression of antiviral genes by SARS-CoV-2 NSP1.

机构信息

RNA Molecular Biology Laboratory, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

出版信息

PLoS One. 2024 Jan 26;19(1):e0297262. doi: 10.1371/journal.pone.0297262. eCollection 2024.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evades the innate immune machinery through multiple viral proteins, including nonstructural protein 1 (NSP1). While NSP1 is known to suppress translation of host mRNAs, the mechanisms underlying its immune evasion properties remain elusive. By integrating RNA-seq, ribosome footprinting, and ChIP-seq in A549 cells we found that NSP1 predominantly represses transcription of immune-related genes by favoring Histone 3 Lysine 9 dimethylation (H3K9me2). G9a/GLP H3K9 methyltransferase inhibitor UNC0638 restored expression of antiviral genes and restricted SARS-CoV-2 replication. Our multi-omics study unravels an epigenetic mechanism underlying host immune evasion by SARS-CoV-2 NSP1. Elucidating the factors involved in this phenomenon, may have implications for understanding and treating viral infections and other immunomodulatory diseases.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)通过多种病毒蛋白,包括非结构蛋白 1(NSP1),逃避先天免疫机制。虽然已知 NSP1 抑制宿主 mRNA 的翻译,但它的免疫逃避特性的机制仍不清楚。通过整合 A549 细胞中的 RNA-seq、核糖体足迹和 ChIP-seq,我们发现 NSP1 主要通过促进组蛋白 3 赖氨酸 9 二甲基化(H3K9me2)来抑制免疫相关基因的转录。G9a/GLP H3K9 甲基转移酶抑制剂 UNC0638 恢复了抗病毒基因的表达,并限制了 SARS-CoV-2 的复制。我们的多组学研究揭示了 SARS-CoV-2 NSP1 逃避宿主免疫的表观遗传机制。阐明参与这一现象的因素,可能对理解和治疗病毒感染和其他免疫调节性疾病具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d375/10817131/b659088c1b45/pone.0297262.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验